[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2017 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
27-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Dec-2017 [#4]
Profit Trend
QoQ- 26.06%
YoY- 18.04%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 2,384,416 2,401,304 2,471,692 2,323,960 2,281,018 2,272,522 2,473,176 -2.40%
PBT 77,706 81,354 114,828 73,064 70,930 75,854 111,108 -21.19%
Tax -26,160 -34,644 -44,472 -17,977 -27,065 -17,836 -34,076 -16.14%
NP 51,546 46,710 70,356 55,087 43,865 58,018 77,032 -23.47%
-
NP to SH 50,708 45,960 70,344 53,823 42,697 56,886 75,692 -23.41%
-
Tax Rate 33.67% 42.58% 38.73% 24.60% 38.16% 23.51% 30.67% -
Total Cost 2,332,869 2,354,594 2,401,336 2,268,873 2,237,153 2,214,504 2,396,144 -1.76%
-
Net Worth 522,618 519,642 524,838 526,888 531,892 541,894 544,360 -2.67%
Dividend
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Div 48,535 46,767 51,964 49,314 44,973 41,484 41,475 11.03%
Div Payout % 95.71% 101.76% 73.87% 91.62% 105.33% 72.93% 54.79% -
Equity
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Net Worth 522,618 519,642 524,838 526,888 531,892 541,894 544,360 -2.67%
NOSH 260,505 259,821 259,821 259,821 259,821 259,279 259,219 0.33%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin 2.16% 1.95% 2.85% 2.37% 1.92% 2.55% 3.11% -
ROE 9.70% 8.84% 13.40% 10.22% 8.03% 10.50% 13.90% -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
RPS 917.05 924.21 951.31 895.38 879.14 876.47 954.09 -2.60%
EPS 19.51 17.68 27.08 20.74 16.45 21.94 29.20 -23.55%
DPS 18.67 18.00 20.00 19.00 17.33 16.00 16.00 10.82%
NAPS 2.01 2.00 2.02 2.03 2.05 2.09 2.10 -2.87%
Adjusted Per Share Value based on latest NOSH - 259,821
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
RPS 165.44 166.61 171.50 161.25 158.27 157.68 171.60 -2.40%
EPS 3.52 3.19 4.88 3.73 2.96 3.95 5.25 -23.37%
DPS 3.37 3.24 3.61 3.42 3.12 2.88 2.88 11.03%
NAPS 0.3626 0.3606 0.3642 0.3656 0.3691 0.376 0.3777 -2.68%
Price Multiplier on Financial Quarter End Date
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Date 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 -
Price 2.89 2.88 4.28 4.60 4.14 4.58 4.89 -
P/RPS 0.32 0.31 0.45 0.51 0.47 0.52 0.51 -26.68%
P/EPS 14.82 16.28 15.81 22.18 25.16 20.88 16.75 -7.83%
EY 6.75 6.14 6.33 4.51 3.97 4.79 5.97 8.52%
DY 6.46 6.25 4.67 4.13 4.19 3.49 3.27 57.37%
P/NAPS 1.44 1.44 2.12 2.27 2.02 2.19 2.33 -27.42%
Price Multiplier on Announcement Date
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Date 19/11/18 17/08/18 16/05/18 27/02/18 15/11/17 16/08/17 16/05/17 -
Price 3.09 3.11 4.07 4.04 3.82 4.19 4.72 -
P/RPS 0.34 0.34 0.43 0.45 0.43 0.48 0.49 -21.60%
P/EPS 15.84 17.58 15.03 19.48 23.21 19.10 16.16 -1.32%
EY 6.31 5.69 6.65 5.13 4.31 5.24 6.19 1.28%
DY 6.04 5.79 4.91 4.70 4.54 3.82 3.39 46.91%
P/NAPS 1.54 1.56 2.01 1.99 1.86 2.00 2.25 -22.31%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment